Showing results (671-680 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|June 15, 2018
Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the DiseaseAnanda Mukherjee, Amanda L Patterson, Jitu W George, et al.
Molecular Cancer Therapeutics|August 2, 2018
Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer ModelsHongmei Jiang, Mai Xu, Lin Li, et al.
Molecular Cancer Therapeutics|August 8, 2018
Phage Display-Derived Peptide-Based Dual-Modality Imaging Probe for Bladder Cancer Diagnosis and Resection Postinstillation: A Preclinical StudyLi Peng, Wenting Shang, Pengyu Guo, et al.
Molecular Cancer Therapeutics|May 24, 2017
Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer CellsXinzhe Li, Bo Li, Zhenhong Ni, et al.
Molecular Cancer Therapeutics|May 20, 2017
Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC DegradationJohn K Simmons, Aleksandra M Michalowski, Benjamin J Gamache, et al.
Molecular Cancer Therapeutics|May 20, 2017
Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody-Drug Conjugate Targeting 5T4Jay Harper, Christopher Lloyd, Nazzareno Dimasi, et al.
Molecular Cancer Therapeutics|May 20, 2017
Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3Chuan Xing Wu, Aimin Xu, Cathy C Zhang, et al.
Molecular Cancer Therapeutics|May 20, 2017
Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor ErlotinibJudith Raimbourg, Marie-Pierre Joalland, Mathilde Cabart, et al.
Molecular Cancer Therapeutics|April 27, 2018
Improving the In Vivo Efficacy of an Anti-Tac (CD25) Immunotoxin by Pseudomonas Exotoxin A Domain II EngineeringGilad Kaplan, Ronit Mazor, Fred Lee, et al.
Molecular Cancer Therapeutics|April 27, 2018
Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In VivoMengqiu Song, Xuejiao Liu, Kangdong Liu, et al.
Pageof 599